Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Liabilities (2020 - 2025)

NeuroPace has reported Total Liabilities over the past 6 years, most recently at $86.5 million for Q4 2025.

  • Quarterly results put Total Liabilities at $86.5 million for Q4 2025, changed 0.12% from a year ago — trailing twelve months through Dec 2025 was $86.5 million (changed 0.12% YoY), and the annual figure for FY2025 was $86.5 million, changed 0.12%.
  • Total Liabilities for Q4 2025 was $86.5 million at NeuroPace, down from $88.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for NPCE hit a ceiling of $88.7 million in Q3 2025 and a floor of $58.3 million in Q2 2021.
  • Median Total Liabilities over the past 5 years was $82.0 million (2023), compared with a mean of $77.6 million.
  • Biggest five-year swings in Total Liabilities: plummeted 59.59% in 2021 and later skyrocketed 32.09% in 2022.
  • NeuroPace's Total Liabilities stood at $60.1 million in 2021, then surged by 32.09% to $79.3 million in 2022, then increased by 9.67% to $87.0 million in 2023, then decreased by 0.42% to $86.6 million in 2024, then decreased by 0.12% to $86.5 million in 2025.
  • The last three reported values for Total Liabilities were $86.5 million (Q4 2025), $88.7 million (Q3 2025), and $86.7 million (Q2 2025) per Business Quant data.